In corroboration of this observation, silencing of AURKB resensitized NSCLC cells to these chemotherapeutic agents by establishing correct chromosome segregation and restoring p53 expression, which suggests AURKB as a promising therapeutic target in this malignancy. The gene discussed is AURKB; the disease is non-small cell lung carcinoma.